These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48 related articles for article (PubMed ID: 14358385)
1. [Observations on the absorption by rectal route of purified diphtheria toxoid]. POSTERARO G; PRATO C; SOPRANO D Riv Ist Sieroter Ital; 1954; 29(6):554-8. PubMed ID: 14358385 [No Abstract] [Full Text] [Related]
2. Effect of aluminium phosphate and aluminium hydroxide on the antigenicity of purified diphtheria toxoid. HALONEN P; JANNES L Ann Med Exp Biol Fenn; 1955; 33(1-2):5-11. PubMed ID: 14388313 [No Abstract] [Full Text] [Related]
3. Risk of medically attended local reactions following diphtheria toxoid containing vaccines in adolescents and young adults: a Vaccine Safety Datalink study. Jackson LA; Yu O; Nelson J; Belongia EA; Hambidge SJ; Baxter R; Naleway A; Nordin J; Baggs J; Iskander J Vaccine; 2009 Aug; 27(36):4912-6. PubMed ID: 19567245 [TBL] [Abstract][Full Text] [Related]
4. Prevalence and correlates of diphtheria toxoid antibodies in children and adults in Israel. Valinsky L; Simhoni S; Bassal R; Agmon V; Yishai R; Green MS; Cohen D Clin Microbiol Infect; 2006 Oct; 12(10):968-73. PubMed ID: 16961632 [TBL] [Abstract][Full Text] [Related]
5. Quality control of routine, experimental and real-time aged diphtheria toxoids by in vitro analytical techniques. Metz B; Jiskoot W; Mekkes D; Kingma R; Hennink WE; Crommelin DJ; Kersten GF Vaccine; 2007 Sep; 25(39-40):6863-71. PubMed ID: 17707558 [TBL] [Abstract][Full Text] [Related]
6. A FIELD investigation of PTAP (purified toxoid, aluminium-phosphate-precipitated). Mon Bull Minist Health Public Health Lab Serv; 1954 Jul; 13():127-41. PubMed ID: 13185234 [No Abstract] [Full Text] [Related]
7. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. America Academy of Pediatrics Commitee on Infectious Diseases Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131 [TBL] [Abstract][Full Text] [Related]
8. Spontaneously reported adverse reactions after diphtheria-tetanus revaccination at 4-6 years of age--a comparison of two vaccines with different amounts of diphtheria toxoid. Thierry-Carstensen B; Sjølin Frederiksen M; Andersen PH; Stellfeld M Vaccine; 2004 Dec; 23(5):668-71. PubMed ID: 15542188 [TBL] [Abstract][Full Text] [Related]
9. Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents. Pichichero ME; Blatter MM; Kennedy WA; Hedrick J; Descamps D; Friedland LR Pediatrics; 2006 Apr; 117(4):1084-93. PubMed ID: 16585302 [TBL] [Abstract][Full Text] [Related]
11. In vitro pyrogenicity of the diphtheria, tetanus and acellular pertussis components of a trivalent vaccine. Carlin G; Viitanen E Vaccine; 2005 May; 23(28):3709-15. PubMed ID: 15882532 [TBL] [Abstract][Full Text] [Related]
12. Enhanced transdermal-immunization with diptheria-toxoid using local hyperthermia. Upadhyay P Vaccine; 2006 Jul; 24(27-28):5593-8. PubMed ID: 16735086 [TBL] [Abstract][Full Text] [Related]
13. Acellular pertussis vaccine boosters combined with diphtheria and tetanus toxoid boosters for adolescents: safety and immunogenicity assessment when preceded by different 5-dose DTaP/DTwP schedules. Pichichero ME; Casey JR; Francis AB; Marsocci SM; Murphy M; Hoeger W; Cleary C Clin Pediatr (Phila); 2006 Sep; 45(7):613-20. PubMed ID: 16928838 [TBL] [Abstract][Full Text] [Related]
14. Introduction of tetanus toxoid and reduced diphtheria toxoid vaccines in the United States. Mink CM Pediatr Infect Dis J; 2006 Apr; 25(4):363-4. PubMed ID: 16567991 [No Abstract] [Full Text] [Related]
16. A case of granuloma annulare in a child following tetanus and diphtheria toxoid vaccination. Baskan EB; Tunali S; Kacar SD; Adim SB; Saricaoglu H J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):639-40. PubMed ID: 16164728 [No Abstract] [Full Text] [Related]
17. Respiratory diphtheria among highly vaccinated military trainees in Latvia: improved protection from DT compared with Td booster vaccination. Ohuabunwo C; Perevoscikovs J; Griskevica A; Gargiullo P; Brilla A; Viksna L; Glismann S; Wharton M; Vitek C Scand J Infect Dis; 2005; 37(11-12):813-20. PubMed ID: 16308214 [TBL] [Abstract][Full Text] [Related]
18. Antibody response to a stimulating dose of tetanus toxoid in children previously immunized with combined diphtheria and tetanus toxoids, (C.D.T.). WIENER S; PATTERSON RW; MACKENZIE EF Med J Aust; 1955 Apr; 42(1 18):633-6. PubMed ID: 14382870 [No Abstract] [Full Text] [Related]
19. Evaluation of diphtheria convalescent patients to serve as donors for the production of anti-diphtheria immunoglobulin preparations. Bissumbhar B; Rakhmanova AG; Berbers GA; Iakolev A; Nosikova E; Melnick O; Ovtcharenko E; Rümke HC; Ruitenberg EJ Vaccine; 2004 May; 22(15-16):1886-91. PubMed ID: 15121299 [TBL] [Abstract][Full Text] [Related]
20. Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria-pertussis-tetanus (DPT) combination vaccine. Isaka M; Komiya T; Takahashi M; Yasuda Y; Taniguchi T; Zhao Y; Matano K; Matsui H; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K Vaccine; 2004 Aug; 22(23-24):3061-8. PubMed ID: 15297056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]